Oncology Central

Past, present and future targets for immunotherapy in ovarian cancer

0

Ovarian cancer is the leading cause of death from gynecologic malignancy in the US. Treatments have improved with conventional cytotoxic chemotherapy and advanced surgical techniques but disease recurrence is common and fatal in nearly all cases. Current evidence suggests that the immune system and its ability to recognize and eliminate microscopic disease is paramount in preventing recurrence.

To view restricted content, please:
Share:

Leave A Comment